Cardiomegaly medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor in Chief:''' {{CZ}} | ||
==Overview== | ==Overview== | ||
There are both acute and chronic pharmacotherapies used to manage the cardiomegaly. [[Diuretics]] and [[ACE inhibitor]]s are the standard therapy for chronic management of cardiomegaly. Acute therapies include [[digoxin]], [[diuretic]]s, [[antiarrhythmic]]s, pre-load and after-load reducers. | There are both acute and chronic pharmacotherapies used to manage the cardiomegaly. [[Diuretics]] and [[ACE inhibitor]]s are the standard therapy for chronic management of cardiomegaly. Acute therapies include [[digoxin]], [[diuretic]]s, [[antiarrhythmic]]s, pre-load and after-load reducers. | ||
==Medical Therapy== | ==Medical Therapy== | ||
=== Acute Pharmacotherapies === | === Acute Pharmacotherapies === | ||
Administration of [[digoxin]], [[diuretic]]s, [[antiarrhythmics]] and/or [[preload]] and [[afterload]] reducers per clinical indication. | Administration of [[digoxin]], [[diuretic]]s, [[antiarrhythmics]] and/or [[preload]] and [[afterload]] reducers as per clinical indication. | ||
=== Chronic Pharmacotherapies === | === Chronic Pharmacotherapies === | ||
A combination of [[diuretic]]s and [[angiotensin converting enzyme]] ([[ACE]]) inhibition is currently the standard of care. [[Digoxin]] may reduce the frequency of rehospitalization, but does not improve mortality. | A combination of [[diuretic]]s and [[angiotensin converting enzyme]] ([[ACE]]) inhibition is currently the standard of care. [[Digoxin]] may reduce the frequency of rehospitalization, but does not improve mortality. | ||
== References == | == References == | ||
Revision as of 04:17, 9 August 2013
|
Cardiomegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiomegaly medical therapy On the Web |
|
Directions to Hospitals Treating Cardiomegaly medical therapy |
|
Risk calculators and risk factors for Cardiomegaly medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
There are both acute and chronic pharmacotherapies used to manage the cardiomegaly. Diuretics and ACE inhibitors are the standard therapy for chronic management of cardiomegaly. Acute therapies include digoxin, diuretics, antiarrhythmics, pre-load and after-load reducers.
Medical Therapy
Acute Pharmacotherapies
Administration of digoxin, diuretics, antiarrhythmics and/or preload and afterload reducers as per clinical indication.
Chronic Pharmacotherapies
A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.